Pentoxifylline for blood vessel calcium buildup in kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a pill called pentoxifylline to see if it can help slow down calcium buildup in blood vessels, which is common in people with kidney disease. Taking part may help protect your heart and blood vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have chronic kidney disease (CKD)
- Your kidney function is moderately reduced, but you are not yet on dialysis
- You are not currently receiving hemodialysis
- You have not had a kidney transplant in the past
- You are not pregnant and do not plan to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of dialysis fluid affect calcium buildup in the blood vessels of people with kidney disease on hemodialysis. It may help improve heart health for dialysis patients.
This study tests an investigational drug (RVX000222) to see if it helps people with kidney failure who are on dialysis. The drug is given in two parts and may help improve heart health, which is often a concern for dialysis patients.
This study tests how well a generic version of pentoxifylline, a medicine used to improve blood flow, works compared to the brand-name version. It is for healthy adults to check if the two versions are the same in the body.
This trial tests whether adding pentoxifylline (a pill that improves blood flow and reduces inflammation) to your usual topical treatments can help clear mild-to-moderate plaque psoriasis. If you have had psoriasis for a while and it covers 3-10% of your body, this study might offer a new option.
This study tests if pentoxifylline, a medicine typically used for circulation, can help reduce joint inflammation in people with rheumatoid arthritis who still have active symptoms despite taking standard DMARDs.
This trial tests if the cholesterol-lowering drug bempedoic acid can slow kidney function loss in people with autosomal dominant polycystic kidney disease (ADPKD). It may offer a new option to protect your kidneys.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.